Andrea Gomez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
Journal: Neurology
Published: May 27, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
Journal: Neurology
Published: January 28, 2026
Prospective cohort study of the impact of preventive migraine treatment on vestibular function and symptoms: The SPIRAL study.
Journal: Clinical neurology and neurosurgery
Published: September 27, 2025
Retrospective cohort study of anti-CGRP monoclonal antibody unresponsive migraine individuals treated with atogepant: The RESCUE study.
Journal: Cephalalgia : an international journal of headache
Published: June 12, 2025
Dual therapy with Erenumab and onabotulinumtoxinA: No synergistic effect in chronic migraine: A retrospective cohort study.
Journal: Pain practice : the official journal of World Institute of Pain
Published: February 10, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026